Endothelial Nitric Oxide Synthase Intron 4 Polymorphism Influences the Progression of Renal Disease
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIM: Nitric oxide is a potent regulator of intrarenal hemodynamics and may influence the renal function. We investigated whether polymorphism of intron 4 of the endothelial constitutive nitric oxide synthase (ecNOS) gene is related to the progression of chronic renal failure. METHODS: Polymorphism of ecNOS intron 4 was studied in 1,005 hemodialysis patients (710 with nondiabetic nephropathy and 295 with diabetic nephropathy) and was compared with the findings in 189 healthy subjects. ecNOS genotypes were determined by the polymerase chain reaction, followed by agarose gel electrophoresis. RESULTS: The frequencies of ecNOS4a/a, ecNOS4a/b, and ecNOS4b/b genotypes were, respectively, 0% (0/189), 13.8% (26/189), and 86.2% (163/189) in the control group; 1.7% (12/710), 22.1% (157/710), and 76.2% (541/710) in the nondiabetic nephropathy group, and 1.0% (3/295), 22.7% (67/295), and 76.3% (225/295) in the diabetic nephropathy group. The frequency of ecNOS4a (ecNOSa/a and ecNOSa/b) was significantly higher in both the nondiabetic group and in the diabetic group than in the controls (p = 0.0025 and p = 0.0438, respectively). CONCLUSION: There was a significantly higher frequency of the a allele of intron 4 in both nondiabetic and diabetic hemodialysis patients, so the polymorphism of intron 4 of the ecNOS gene may have a wide influence on the progression of renal disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistently, polymorphisms in KKS-related genes (ACE, BDKRB2, NOS3, KLK1) are associated with an increased risk of acute and chronic renal injury in humans [22–25].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [22]
Citations
Cites
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.
Bredt, D. S., & Snyder, S. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.682 · Cited by 3,284 · cited 1×
“ecNOS is expressed constitutively and is associated with vascular smooth muscle relaxation and platelet aggregation [”
BackgroundHypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Schmidt, H. H. H. W., & Walter, U. (1994) · Cell · doi:10.1016/0092-8674(94)90267-4 · Cited by 1,476
Marsden, P. A., Heng, H. H., Scherer, S. W., Stewart, R. J., Hall, A. V., Shi, X. M., Tsui, L. C., & Schappert, K. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85359-0 · Cited by 871
Baylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729 · cited 1×
“NO maintains basal vasodilation, probably in response to changes of pulsatile flow and shear stress. Chronic inhibition of NO synthesis in rats has been shown to cause hypertension and progressive renal damage [”
BackgroundWang, X. L., Sim, A. S., Badenhop, R. F., Mccredie, R. M., & Wilcken, D. E. L. (1996) · Nature Medicine · doi:10.1038/nm0196-41 · Cited by 562 · cited 1×
“have suggested that five tandem repeats of a 27-bp consensus sequence of intron 4 might serve as markers for the ecNOS gene. Wang et al. [”
BackgroundControl of regional blood flow by endothelium-derived nitric oxide.
Gardiner, S. M., Compton, A. M., Bennett, T., Palmer, R. M., & Moncada, S. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.486 · Cited by 436
Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses
Tolins, J. P., Palmer, R. M., Moncada, S., & Raij, L. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.258.3.h655 · Cited by 248
Gene Structure, Polymorphism and Mapping of the Human Endothelial Nitric Oxide Synthase Gene
Nadaud, S., Bonnardeaux, A., Lathrop, M., & Soubrier, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1146 · Cited by 226 · cited 1×
“NO is produced from L -arginine by NO synthase (NOS). Three distinct isoforms of NOS have been identified in humans: endothelial constitutive NOS (ecNOS), neuronal NOS, and inducible NOS. ecNOS is encoded by a gene located on chromosome 7q35–36, comprising 26 exons that span 21 kb, and is expressed by the endothelium [”
BackgroundEffects of acute nitric oxide inhibition on rat glomerular microcirculation
Zatz, R., & de Nucci, G. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.2.f360 · Cited by 187
Cited by
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Mouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
Zhao, H. J., Wang, S., Cheng, H., Zhang, M.-Z., Takahashi, T., Fogo, A. B., Breyer, M. D., & Harris, R. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070798 · Cited by 359
“Other studies also have found an association of these polymorphisms with nondiabetic causes of ESRD (9,34).”
BackgroundInfluentialRole of nitric oxide in diabetic nephropathy
Prabhakar, S. S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.04.005 · Cited by 167
The kallikrein-kinin system in health and in diseases of the kidney
Kakoki, M., & Smithies, O. (2009) · Kidney International · doi:10.1038/ki.2008.647 · Cited by 106
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript progression of CRF into ESRD, including ACE,164,165 Bdkrb1,166,167 Bdkrb2,167,168 and Nos3.”
Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians
Ahluwalia, T. S., Ahuja, M., Singh, T., Kohli, H. S., Sud, K., Bhansali, A. K., & Khullar, M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9759-8 · Cited by 87
“Variable results have been reported for the association of 4b/4a variable number of tandem repeats in intron 4 of eNOS with renal disease [14, 16, 19, 20].”
BackgroundDiagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Tailor, P. D., Kodeboyina, S. K., Bai, S., Patel, N., Sharma, S., Ratnani, A., Copland, J. A., She, J., & Sharma, A. K. (2018) · Oncotarget · doi:10.18632/oncotarget.24947 · Cited by 66
Diabetic nephropathy: Of mice and men
Breyer, M. D., Böttinger, E. P., Brosius, F. C., Coffman, T. M., Fogo, A. B., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.004 · Cited by 60
Zintzaras, E., Papathanasiou, A. A., & Stefanidis, I. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2046b · Cited by 56
Shoukry, A., Shalaby, S. M., Abdelazim, S., Abdelazim, M., Ramadan, A., Ismail, M. I., & Fouad, M. M. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0218 · Cited by 46
“However, other studies concluded that eNOS intron 4 polymorphism is associated with an increased risk for progression to DN in type 2 diabetes (Neugebauer et al. , 2000; Asakimori et al. , 2001).”
Asakimori, Y., Yorioka, N., Taniguchi, Y., Ito, T., Ogata, S., Kyuden, Y., & Kohno, N. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000065041 · Cited by 45
“Moreover, we recently reported that intron 4 might influence the progression of renal failure in both diabetic and nondiabetic nephropathy [”
BackgroundSelf-citationBuraczyńska, M., Książek, P., Załuska, W., Nowicka, T., & Książek, A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh077 · Cited by 44
“An association of the 4a allele of the ecNOS gene with coronary heart disease and renal disease was reported [4,8,9].”
BackgroundThe Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Cilenšek, I., Mankoč, S., Petrovič, M. G., & Petrovič, D. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1537-8 · Cited by 42
“These results, while accordant with previous reports for other diabetic microvascular complication, namely, diabetic nephropathy (DN) [23, 41–43], are not in agreement with other studies sug-”
ResultAsakimori, Y., Yorioka, N., Tanaka, J., & Kohno, N. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00030-1 · Cited by 36
Self-citationAssociation of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes
dos Santos, K. G., Crispim, D., Canani, L. H. S., Ferrugem, P. T., Gross, J. L., & Roisenberg, I. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.029 · Cited by 35
“Moreover, several other authors did not find any association of the polymorphism in exon 7 with renal insufficiency in African American [25], European American [15], Finnish [34], Australian [23], and Japanese [30,32] type 2 diabetic patients, as also observed in the present study for Caucasian-Brazilians.”
BackgroundResultInfluentialEndothelial Nitric Oxide Synthase Gene Intron 4 Polymorphism in Type 2 Diabetes Mellitus
Książek, P., Wojewoda, P., Muc, K., & Buraczyńska, M. (2003) · Molecular Diagnosis · doi:10.1007/bf03260027 · Cited by 33
Bellini, M. H., Figueira, M., Piccoli, M. F., Marumo, J. T., Cendoroglo, M. S., Neto, M. C., Dalboni, M. A., Batista, M. C., Góes, M. Â., & Schor, N. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00787.x · Cited by 32
“Asakimori et al.(24) studied the frequency of eNOS intron 4 polymorphism in non-diabetic and DN patients undergoing haemodialysis.”
BackgroundRamani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
Staalsø, J. M., Bergström, A., Edsen, T., Weikop, P., Romner, B., & Olsen, N. V. (2013) · Stroke · doi:10.1161/strokeaha.111.000605 · Cited by 29
Toward a Mouse Model of Diabetic Nephropathy: Is Endothelial Nitric Oxide Synthase the Missing Link?
Quaggin, S. E., & Coffman, T. M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121396 · Cited by 26
Lamnissou, K., Zirogiannis, P., Trygonis, S., Demetriou, K., Pierides, A., Koptides, M., & Deltas, C. C. (2004) · Genetic Testing · doi:10.1089/gte.2004.8.319 · Cited by 25
“Our results do not corroborate previous results reported by others (Yokohama et al. , 1998; Wang et al. , 1999; Asakimori et al. , 2001).”
Multifactorial Determination of Hypertensive Nephroangiosclerosis
Tylicki, L., Rutkowski, B., & Hörl, W. H. (2002) · Kidney & Blood Pressure Research · doi:10.1159/000068698 · Cited by 25
Asakimori, Y., Yorioka, N., Tanaka, J., Takasugi, N., Harada, S., Shigemoto, K., Yamashita, K., Usui, K., Arita, M., & Kohno, N. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.034 · Cited by 21
Self-citationYun, Z., Yu-Ping, Y., Tong, Z., Yang, S., Yang, F. Y., & Fang, S. (2014) · Renal Failure · doi:10.3109/0886022x.2014.900601 · Cited by 17
Endothelial nitric oxide synthase gene intron 4 a/b VNTR polymorphism in children with APSGN
Dursun, H., Noyan, A., Matyar, S., Büyükçelik, M., Soran, M., Cengız, N., Şeydaoğlu, G., Attila, G., Bayazıt, A. K., & Anarat, A. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0202-7 · Cited by 14
“[24] found a significantly higher frequency of the a allele of intron 4 in both nondiabetic and diabetic hemodialysis patients.”
BackgroundGunawan, A., Fajar, J. K., Tamara, F., Mahendra, A. I., Ilmawan, M., Purnamasari, Y., Kartini, D. A., Winoto, E. S., Saifillah, E. S., Wulandari, D. S., et al. (2020) · F1000Research · doi:10.12688/f1000research.22989.1 · Cited by 12
The kallikrein–kinin system in diabetic kidney disease
Liu, W., Stanton, R. C., & Zhang, Z. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000344 · Cited by 12
Zhang, Y., Xiao, H., Zeng, X., Zuo, H., & Xu, Y. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1062339 · Cited by 12
“In relation to the eNOS-T786C polymorphism in the promoter region, the C allele has been associated with an increased risk of DN in North Asian Indians11 and with endstage renal disease (ESRD) in Japanese.17 However, some studies did not observe an association between this polymorphism and renal insufficiency in Tunis…”
BackgroundStaalsø, J. M., Edsen, T., Kotinis, A., Romner, B., Springborg, J. B., & Olsen, N. V. (2014) · Journal of neurosurgery · doi:10.3171/2014.5.jns131572 · Cited by 9
The complex genetics of scleroderma
Ahmed, S., Tan, F. K., & Arnett, F. C. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01098-7 · Cited by 9
Endothelial Nitric Oxide Genotypes and Haplotypes Are Not Associated with End-Stage Renal Disease
Marson, B. P., Dickel, S., Ishizawa, M. H., Metzger, I. F., Izidoro‐Toledo, T. C., da Costa, B. E. P., Poli‐de‐Figueiredo, C. E., & Tanus-Santos, J. E. (2010) · DNA and Cell Biology · doi:10.1089/dna.2010.1106 · Cited by 8
“While we found no significant association, this polymorphism affected the development of ESRD in different populations (Zanchi et al. , 2000; Asakimori et al. , 2001; Nagase et al. , 2003; Bur-aczynska et al. , 2004; Bellini et al. , 2007), with the 4a allele being associated with ESRD.”
Association of eNOS gene intron 4 a/b VNTR polymorphisms in children with nephrotic syndrome
Dursun, H., Noyan, A., Matyar, S., Büyükçelik, M., Soran, M., Cengız, N., Bayazıt, A. K., Şeydaoğlu, G., Attila, G., & Anarat, A. (2013) · Gene · doi:10.1016/j.gene.2013.03.080 · Cited by 6
Wang, D., Liu, L., Zhang, C., Lu, W., Wu, F., & He, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.887415 · Cited by 5
Santovito, A., Cervella, P., & Delpero, M. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1492-4 · Cited by 3
Complex disease genetics enters the high street
Bain, S. C., & Rippin, J. D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01107.x · Cited by 1
Serum Nitric Oxide as a Biochemical Marker for Diabetic Nephropathy
Mohammed, E. Y., Al-Timimi, D. J., Alkass, S. Y., Mehdi, A. H., & Mohammed, A. I. (2014) · Cited by 1
Manal, F., Sabry, S. M., Badr, A., Eman, A. A. A. M., Kamel, S., & Elsaie, G. (2011) · InTech eBooks · doi:10.5772/21731
“GT substitution in exon7 in codon 298, T786 mutation in the 5 ́ flanking region and high numbers of CVD , which have been repeated in intron 13 of eNOS gene are also known to be associated with an excess of risk of coronary artery disease (CAD) [Asakimori et al., 2001].”
BackgroundInfluentialGenetic analysis of the microvascular complications of diabetes mellitus
Cross, D. F. (2002) · PEARL (University of Plymouth) · doi:10.24382/4945
Moorthy, S., & Koshy, T. (2024) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2024.2317411
“In agreement with the findings of this study, an association was reported with the ‘a’ allele with ESRD in Brazilians and Poles, [14,15] with progression of chronic renal failure in the Japanese, [16] and with DN in the Japanese.”
Park, S. W. (2021) · F1000Research · doi:10.5256/f1000research.55513.r81755
Metadata
- Authors
- Asakimori, Y., Yorioka, N., Yamamoto, I., Okumoto, S., Doi, S., Hirai, T., & Taniguchi, Y.
- Affiliations
- Hiroshima University (JP)
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 89
- Issue
- 2
- Pages
- 219-223
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2053484534
- Cited by
- 41
- References
- 20
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- The Nephron journals/Nephron journals (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- endothelial nitric oxide synthase, diabetic nephropathy, non-diabetic nephropathy, hemodialysis patients, nitric oxide, intrarenal hemodynamics, genetic susceptibility
- MeSH terms
- Adult, Aged, Diabetic Nephropathies, Female, Genotype, Humans, Introns, Kidney Failure, Chronic, Male, Middle Aged, Polymorphism, Genetic, Logistic Models, Disease Progression, Nitric Oxide Synthase, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.